About this trial
The primary goal of the patient-led follow-up from home, is the improvement of quality of life and the reduction of stress in patients, while obtaining a more complete picture of their health status.
A series of assessments are performed in the home setting:
* Blood withdrawal for CEA determination * Quality of life questionnaires to assess both mental and physical symptoms * Vital parameters using a Smart Sensor
Eligibility criteria
Qualifiers
Age ≥ 21 years
Histologically confirmed colorectal adenocarcinoma without distant metastasis and treated with curative intent surgical resection less than 6 months ago
Scheduled or currently undergoing postoperative surveillance according to national guidelines
Written informed consent by the patient
Disqualifiers
Patients with a severely complicated postoperative course, needing in hospital follow- up longer than 6 months postoperatively
Patients enrolled in other studies that require strict adherence to any specific follow-up practice with regular imaging - yearly or more frequent - of the abdomen and/or thorax
Patients with comorbidity or other malignancy that requires imaging of the abdomen and/or thorax every year or more frequent
Patients with active implantable devices - e.g. pacemaker or implantable defibrillator
Trial design
Treatments tested in this trial
- Home-based follow-up
Treatment groups
Sponsors and collaborators
Erasmus Medical Center
Lead sponsor
Lifesignals Inc.
Collaborator
YourBio Health
Collaborator
TU Delft
Collaborator
Amphia Hospital
Collaborator
Leiden University Medical Center (LUMC)
Collaborator
Franciscus Gasthuis & Vlietland (Hospital)
Collaborator